In this interview, Didier discusses his projects and shares advice to the community regarding what kind of activities can help foster progress in the development of rejuvenation biotechnology.
Didier is one of the most active members of the European life extension community, co-president of HEALES (Healthy Life Extension Society), vice-president of French Transhumanist Association Technoprog, and a founding member of the International Longevity Alliance.
He is also a long-term member of the local ecology movement. Didier is currently a lawyer in a Belgian federal government agency for social security. Didier is the main organizer of the biennial scientific conference Eurosymposium on Healthy Ageing, held in Brussels, Belgium.
In this interview, he focused on the extension of healthy human life and the control of technological risks, the so called “existential risks”.
We appreciate Didier taking the time to share his vision with us and we are also grateful to him for his generous contributions to the research projects hosted at Lifespan.io.
Elena has been a longevity activist and advocate since 2013, when she first started to organize educational events to make new evidence-based methods of healthy life extension more popular.
The last few years have seen Elena leading some successful projects in Russia, aimed at spreading the idea of healthy longevity among decision makers as well as the general public. Several years of lobbying resulted in the inclusion of her propositions in the strategic program documents of the Russian Federation related to the problems of the elderly. She is a co-author of the book “Aging Prevention for All” (in Russian, 2015), where, among other topics, she is sharing how to facilitate the adoption of the healthy lifestyle to promote the period of good health.
In 2015, Elena helped to shape and coordinate the successful crowdfunding campaign of the Major Mouse Testing Program – a study of Senolytic drug combinations on mouse lifespan.
In 2017 at LEAF, Elena led a successful advocacy project to include the problems of the elderly into the WHO’s 13th Programme of Work .
Previously Elena has worked as a project manager in the pharmaceutical and advertisement industries, helping to promote new drugs and therapies. This experience helped her to realize that the existing therapies were not 100% effective and could not completely stop age-related diseases – which has ignited an interest for the development of innovative therapies.
Elena graduated with a bachelor’s in both psychology and foreign languages and is now working to earn her MBA at the oldest Russian business school MIRBIS.
In a paper in Frontiers in Genetics, Maël Lemoine of France’s CNRS offers an evolutionary perspective on the hallmarks of aging [1]. This review examines […]
Researchers have developed a biological aging clock based on movement data from wearable devices. Using their clock and the same dataset, they identified a few possibly life-prolonging nutrients and drugs [1]. I move, therefore I am Developing reliable biomarkers […]
We’re happy to report on this episode of Lifespan News that roughly $26 million will be given in grants to people working on age-related research. Script Around $26 million in grant funding has just been made […]
Publishing in Nature Communications’ Cell Death Discovery, a team of Chinese researchers has discovered a reason for thymic involution, the age-related decline […]
The current pandemic has brought mRNA vaccines into the spotlight and have likely sped up the widespread adoption and usage of this technology. Now, a company has its sights […]
This episode of Lifespan News is about Altos Labs, a new billionare-financed company that is pledged to focus on aging. Script There’s a new company focused on solving aging! […]
You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.
Write a comment: